Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Clarametyx Biosciences Logo
Clarametyx Biosciences Growth Score
71
CB Rank
22502
Heat Score
50
Clarametyx Biosciences is a biotechnology company that develops immune-enabling biologic therapies.
Founded
obfuscation
PrivateSeries A Columbus, Ohio, United States1-10 clarametyx.com/
Biotechnology
Health Care
Medical
Pharmaceutical
Overview

Clarametyx Biosciences
Total Funding
obfuscation
Growth Score
71
Heat Score
50

Total Funding
obfuscation
obfuscation
Series A raised
obfuscation
Growth Score71
-10 pts
in past quarter
Heat Score 50
5 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
+2 more milestones
See more interactive data and historical milestones on desktop for the best experience

About Clarametyx Biosciences

CB Rank
22502
Clarametyx Biosciences is a biotechnology company that develops immune-enabling biologic therapies.
Founded
obfuscation
PrivateSeries A Columbus, Ohio, United States1-10 clarametyx.com/
Biotechnology
Health Care
Medical
Pharmaceutical

Funding Rounds

Series A
OBF
in
obfuscation
Series A
OBF
in
obfuscation
Series A
OBF
in
obfuscation

Key People

Details

Legal Name Clarametyx Biosciences, Inc.
Also Known As Clarametyx
Operating Status Active
Company Type For Profit
Founders  Charles McOsker, Juliana Woda, Michael Triplett, Peter Kleinhenz
About the Company
Clarametyx Biosciences is a late preclinical stage biotechnology company developing targeted, immune-enabling biologic therapies to counter persistent infections associated with biofilms.
Phone Number 614.686.2689
Contact Email info@clarametyx.com
Predictions & Insights

Growth Insight

See this Growth Insight
Clarametyx Biosciences is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

CMTX-101
An immune-enabling antibody therapy that targets and dismantles bacterial biofilms to enhance antibiotic and immune system effectiveness against bacterial infections.
CMTX-301
A vaccine candidate designed to prevent bacterial biofilm formation by inducing an immune response against biofilm structural proteins, reducing infection incidence and severity.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 8
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - Clarametyx Biosciences Logo
Series A - Clarametyx Biosciences
—
obfuscation
— Series A
obfuscation
Series A - Clarametyx Biosciences Logo
Series A - Clarametyx Biosciences
—
obfuscation
— Series A
obfuscation
Series A - Clarametyx Biosciences Logo
Series A - Clarametyx Biosciences
—
obfuscation
— Series A
obfuscation
Series A - Clarametyx Biosciences Logo
Series A - Clarametyx Biosciences
—
obfuscation
— Series A
obfuscation
Series A - Clarametyx Biosciences Logo
Series A - Clarametyx Biosciences
—
obfuscation
— Series A

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 8
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - Clarametyx Biosciences Logo
Series A - Clarametyx Biosciences
—
obfuscation
— Series A
obfuscation
Series A - Clarametyx Biosciences Logo
Series A - Clarametyx Biosciences
—
obfuscation
— Series A
obfuscation
Series A - Clarametyx Biosciences Logo
Series A - Clarametyx Biosciences
—
obfuscation
— Series A
obfuscation
Series A - Clarametyx Biosciences Logo
Series A - Clarametyx Biosciences
—
obfuscation
— Series A
obfuscation
Series A - Clarametyx Biosciences Logo
Series A - Clarametyx Biosciences
—
obfuscation
— Series A

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 8 Board Members and Advisors 4 Contacts 7

Employee Profiles

Board Members and Advisors

News

News and Press

News•Apr 2, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 9, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 9, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 9, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

601
-68.34%
 in past month

IT Spend

$130.5KThis year, Clarametyx Biosciences is projected to spend $130.5K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Livingetc Logo
Livingetc
82
Washington Post Logo
Washington Post
81
Smart Home Logo
Smart Home
76

Active Website Tech Count

2Clarametyx Biosciences is actively using 2 technologies for its website, according to BuiltWith. These include CommonCrawl Top 5m.
Sub-Organizations
Frequently Asked Questions

Where is Clarametyx Biosciences's headquarters? Clarametyx Biosciences is located in Columbus, Ohio, United States.Who invested in Clarametyx Biosciences? Clarametyx Biosciences has 10 investors including Kineticos Ventures and  Nationwide Children's Hospital.When was the last funding round for Clarametyx Biosciences? Clarametyx Biosciences closed its last funding round on
obfuscation
from a Series A round.Who are Clarametyx Biosciences's competitors? Alternatives and possible competitors to Clarametyx Biosciences may include Teva Pharmaceuticals, Novamab, and  aTyr Pharma.How much funding has Clarametyx Biosciences raised to date? Clarametyx Biosciences has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3120884 1)
|